Australia markets closed

BioMarin Pharmaceutical Inc. (BMRN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
75.07+0.59 (+0.79%)
At close: 04:00PM EDT
75.00 -0.07 (-0.09%)
Pre-market: 08:41AM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
755,127
724,531
587,276
649,158
-
Other short-term investments
318,683
567,006
426,599
416,228
-
Total cash
1,073,810
1,291,537
1,013,875
1,065,386
-
Net receivables
633,704
461,316
373,399
448,351
-
Inventory
1,107,183
894,083
776,669
698,548
-
Other current assets
141,391
104,521
110,442
129,934
-
Total current assets
2,956,088
2,751,457
2,274,385
2,342,219
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
1,933,222
1,875,511
1,756,035
1,668,066
-
Accumulated depreciation
-867,089
-802,145
-720,574
-635,595
-
Net property, plant and equipment
1,066,133
1,073,366
1,035,461
1,032,471
-
Equity and other investments
611,135
333,835
507,793
285,473
-
Goodwill
196,199
196,199
196,199
196,199
-
Intangible assets
294,701
338,569
388,652
417,271
-
Other long-term assets
171,538
176,236
152,121
142,237
-
Total non-current assets
3,885,515
3,623,617
3,730,387
3,505,801
-
Total assets
6,841,603
6,375,074
6,004,772
5,848,020
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
493,877
-
-
-
361,882
Accounts payable
315,509
231,238
199,678
191,429
-
Taxes payable
2,651
16,213
1,213
9,661
-
Accrued liabilities
6,190
8,288
6,043
4,488
-
Deferred revenues
4,620
711
6,956
152
-
Other current liabilities
33,853
28,526
54,495
17,798
-
Total current liabilities
1,177,024
588,884
546,497
492,548
-
Non-current liabilities
Long-term debt
593,095
1,083,019
1,079,077
1,075,145
-
Other long-term liabilities
119,935
100,015
113,529
174,325
-
Total non-current liabilities
713,030
1,183,034
1,192,606
1,249,470
-
Total liabilities
1,890,054
1,771,918
1,739,103
1,742,018
-
Stockholders' equity
Common stock
189
186
184
182
-
Retained earnings
-621,554
-789,199
-930,760
-861,609
-
Accumulated other comprehensive income
-28,788
-3,867
14,432
-16,139
-
Total stockholders' equity
4,951,549
4,603,156
4,265,669
4,106,002
-
Total liabilities and stockholders' equity
6,841,603
6,375,074
6,004,772
5,848,020
-